Refining Alzheimer's disease biological diagnosis with plasma biomarkers: Resolving p‐tau217 “gray zone” with p‐tau181 integration

Abstract BACKGROUND Blood‐based biomarkers offer a less invasive and more scalable alternative to cerebrospinal fluid (CSF) analysis and amyloid‐positron emission tomography (PET) for the biological diagnosis of Alzheimer's disease (AD). Among blood‐based biomarkers (BBMs), plasma phosphorylated tau...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Giulia Giacomucci, Silvia Maria Rita Tabbì, Assunta Ingannato, Silvia Bagnoli, Sonia Padiglioni, Chiara Crucitti, Chiara Sensi, Serena Sanesi, Valentina Moschini, Carmen Morinelli, Giulia Galdo, Valentina Berti, Benedetta Nacmias, Valentina Bessi
Format:	Artigo
Sprog:	Inglês
Udgivet:	Wiley 2026-01-01
Serier:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Fag:	Alzheimer's disease mild cognitive impairment plasma biomarkers plasma GFAP plasma NfL plasma p‐tau181
Online adgang:	https://doi.org/10.1002/dad2.70285
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!